Stockreport

Edesa Biotech Announces Chief Financial Officer Transition [Yahoo! Finance]

Edesa Biotech, Inc. - Common Shares  (EDSA) 
PDF host-directed therapeutics for immuno-inflammatory diseases, today announced the appointment of Peter J. Weiler as Chief Financial Officer, effective May 1, 2025. Mr. We [Read more]